Perspectives for Drug Intervention in Amyloid Diseases

E-ISSN： 1873-5592|5|2|151-158

ISSN： 1389-4501

Source： Current Drug Targets, Vol.5, Iss.2, 2004-02, pp. : 151-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rationalizing a pharmacological intervention on the amyloid precursor protein metabolism

By Racchi M. Govoni S.

Trends in Pharmacological Sciences, Vol. 20, Iss. 10, 1999-10 ,pp. : 418-423

Elsevier

Access to resources Recommend Favorite

A New Technology for Treatment Amyloid Diseases: Serum Amyloid P Component of Inhibitors

Pharmaceutical Innovation, Vol. 11, Iss. 5, 2002-08 ,pp. : 28-30

Adis International

Access to resources Recommend Favorite

Treatment perspectives for the lysosomal storage diseases

By Grabowski Gregory A

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 197-211

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-5, Eosinophilic Diseases and Therapeutic Intervention

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 4, 2003-12 ,pp. : 319-328

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroinflammation in Prion Diseases: Concepts and Targets for Therapeutic Intervention

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 5, 2009-01 ,pp. : 329-341

Bentham Science Publishers

Access to resources Recommend Favorite